Botulinum Toxin Type A (Dysport) in Upper Limb Spasticity After Stroke

Completed

Phase N/A Results

Summary of Purpose

To evaluate the efficacy and safety of Botulinum Toxin A (Dysport) in patients with upper limb spasticity due to stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 January 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Ipsen Limited, Maidenhead, Berkshire, UK.

Trial Design

International, prospective, randomized, double-blind, placebo-controlled, dose-ranging study of 82 patients at 11 West European centers.

Contacts

Not available